PDCD1 and neoplasm: Studies have shown that upregulated PD-L1 expression in tumor cells, particularly when combined with PD-1 expressed by tumor infiltrating activated T cells, can induce exhaustion and inhibit the antitumor immune activity of these effector cells, thereby allowing tumor cell immunity to escape [40].